Do you have Chronic Obstructive Pulmonary Disease (COPD)?
Do you struggle with moderate-to-severe COPD?
If you are still experiencing symptoms and flare-ups despite being on triple inhaler therapy, you may qualify for a clinical study testing a new investigational injection designed to help reduce COPD flare-ups and improve symptoms.
This study is being conducted at select locations in the U.S. If you qualify, you will receive all study-related care and medication at no cost. You may also be compensated for your time and travel.
FILL OUT THE FORM BELOW IF YOU MEET THE FOLLOWING CRITERIA
● Are between the ages of 40 to 85 years old
● Have been diagnosed with COPD for at least 1 year
● Are a current or former smoker
● Have been on a COPD inhaler for at least 3 months
About the Study
This study is testing a new investigational injection (lunsekimig) to see if it can help reduce flare-ups and improve symptoms for people with moderate-to-severe COPD.
If you qualify, you will continue your current inhaler therapy and be randomly assigned to receive either the investigational drug or a placebo (an inactive injection). The study lasts about 60 weeks and includes 12 clinic visits for monitoring and assessments.
Participants will receive all study-related care at no cost, including medical exams, breathing tests, and lab work. Compensation for time and travel may also be available.
Why Participate?
If you qualify, you will receive:
No-cost Study Care
You will receive study-related care from experienced doctors, nurses, and research staff.
Exams
The study will include medical exams, breathing tests, and lab work to monitor your health and COPD symptoms.
Compensation
You may receive compensation for time and travel required to participate in the study.
Chat With a Research Coordinator
© 2025 Accelerate Recruitment | Privacy Policy | Legal Notice